Literature DB >> 6684501

Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors.

R Mira-y-Lopez, E Reich, L Ossowski.   

Abstract

The production of plasminogen activator (PA) and its regulation by hormones and other effectors were studied in organ cultures of primary rat and mouse mammary tumors. PA was quantitated using the radioiodinated fibrin plate method. The level of PA in tumor tissue was 10- to 100-fold higher than that in normal rat or mouse mammary glands; the rates of PA secretion were 10- to 1000-fold higher in the tumor cultures. PA production was stimulated by prolactin and pituitary extracts in N-nitrosomethylurea- and 7,12-dimethylbenz(a)anthracene-induced rat tumors but not in mammary tumor virus-induced mouse tumors; hydrocortisone inhibited PA production in all three tumor categories. Sex hormones and agents such as cholera toxin and retinoic acid effectively modulated enzyme production by some tumors. Three major points of interest emerge from our findings: (a) the pattern of tumor PA response to hormones differs qualitatively and quantitatively from that previously determined for the normal mammary; (b) the profile of responses of tumor PA and tumor growth to hormones shows numerous correlations suggesting that these two parameters may be coordinately regulated; (c) pituitary extracts contain an apparently novel factor that stimulates rat mammary tumor PA synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  cDNA and gene nucleotide sequence of porcine plasminogen activator.

Authors:  Y Nagamine; D Pearson; M S Altus; E Reich
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

2.  Human urokinase gene is located on the long arm of chromosome 10.

Authors:  P Tripputi; F Blasi; P Verde; L A Cannizzaro; B S Emanuel; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

3.  Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.

Authors:  L Ossowski; D Belin
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

4.  Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.

Authors:  R Mira-y-Lopez; J Joseph-Silverstein; D B Rifkin; L Ossowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Separation, purification and N-terminal sequence analysis of a novel leupeptin-sensitive serine endopeptidase present in chemically induced rat mammary tumour.

Authors:  I Eto; C J Grubbs
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

6.  Dexamethasone modulation of in vitro growth pattern and of lung colonization ability in clones of a metastatic BALB/c mammary carcinoma cell line.

Authors:  C De Giovanni; P L Lollini; G Nicoletti; S Grilli; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

Review 7.  Novel thrombolytic agents.

Authors:  M Verstraete; H R Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

8.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

9.  Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.

Authors:  J F Cajot; W D Schleuning; R L Medcalf; J Bamat; J Testuz; L Liebermann; B Sordat
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

10.  Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.

Authors:  M P Stoppelli; P Verde; G Grimaldi; E K Locatelli; F Blasi
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.